Ajanta Pharma's Q2 profit is ₹388 crore, up 49% from a year earlier; revenue rose 33% to ₹1,794 crore
Ajanta Pharma, a drug maker, reported net profit of about ₹388 crore for July to September 2026, against about ₹260 crore a year earlier, on revenue from operations of about ₹1,794 crore, up 33%.
Ajanta Pharma, an Indian drug maker, reported net profit of about ₹388 crore for the July to September 2026 quarter (Q2 of the financial year 2026-27, called FY27). In the same quarter a year earlier it was about ₹260 crore, a rise of 49%. Net profit is what remains after all costs and tax. Revenue from operations (money earned from the company’s business) was about ₹1,794 crore, up 33% from about ₹1,354 crore a year earlier. The figures come from the company’s results presentation dated 30 October 2026, as reported by Multibagg; the reports describe them as consolidated, meaning they include the company and its subsidiaries.
The numbers
| Metric (₹ crore) | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 1,794 | 1,354 | +33% |
| Profit before tax | 535 | 341 | +57% |
| Tax expense | 147 | 81 | n/a |
| Net profit | 388 | 260 | +49% |
- Revenue from operations rose by about ₹440 crore from a year earlier. In the previous quarter, Q1 FY27 (April to June 2026), it was about ₹1,626 crore.
- Profit before tax is profit before income tax is deducted.
- For the first half of FY27 (April to September 2026), Multibagg reports net profit of about ₹722 crore against about ₹516 crore a year earlier (up 40%), and revenue from operations of about ₹3,420 crore against about ₹2,656 crore (up 29%).
Basis of these figures
The primary source (the company’s results filing on BSE and NSE, or its results press release) could not be opened when this article was prepared, so the figures are attributed to the Multibagg report of 30 October 2026 on the company’s results presentation. Sahi’s report of the same day gives net profit as about ₹390 crore against ₹260 crore; the difference from ₹388 crore appears to be rounding, and this article uses the presentation’s figure. The reports reviewed did not mention a dividend for this quarter, so none is reported here. Amounts are in ₹ crore (1 crore = 10 million). Percentages are as reported; the 49% and 33% match the rounded figures given.